Abstract
Gene therapy or recombinant DNA vaccines targeting multiple antigenic components to direct empower the immune system. Antigenic epitopes on neurotoxin Mesobuthus martensii (Buthus martensii) are important determinant of protection against cardiovascular disorder. Small segments 4-YSSDCRVKCVAM-15, 18-SSGKCINSKC-27 of neurotoxin protein called the antigenic epitopes is sufficient for eliciting the desired immune response. In analysis predicted antigenic epitopes neurotoxin protein is seen. Immunization cassettes should be capable of immunizing of broad immunity against both humoral and cellular epitope thus giving vaccines the maximum ability to deal with neurotoxin protein of M. martensii. We have predicted a successful immunization.
Keywords: Neurotoxin, antigenic epitope, GOR, hydrophobicity, hydrophilicity
Current Drug Discovery Technologies
Title: Prediction of Antigenic Epitopes of Neurotoxin Bmbktx1 from Mesobuthus martensii
Volume: 3 Issue: 3
Author(s): Virendra S. Gomase
Affiliation:
Keywords: Neurotoxin, antigenic epitope, GOR, hydrophobicity, hydrophilicity
Abstract: Gene therapy or recombinant DNA vaccines targeting multiple antigenic components to direct empower the immune system. Antigenic epitopes on neurotoxin Mesobuthus martensii (Buthus martensii) are important determinant of protection against cardiovascular disorder. Small segments 4-YSSDCRVKCVAM-15, 18-SSGKCINSKC-27 of neurotoxin protein called the antigenic epitopes is sufficient for eliciting the desired immune response. In analysis predicted antigenic epitopes neurotoxin protein is seen. Immunization cassettes should be capable of immunizing of broad immunity against both humoral and cellular epitope thus giving vaccines the maximum ability to deal with neurotoxin protein of M. martensii. We have predicted a successful immunization.
Export Options
About this article
Cite this article as:
Gomase S. Virendra, Prediction of Antigenic Epitopes of Neurotoxin Bmbktx1 from Mesobuthus martensii, Current Drug Discovery Technologies 2006; 3 (3) . https://dx.doi.org/10.2174/157016306780136817
DOI https://dx.doi.org/10.2174/157016306780136817 |
Print ISSN 1570-1638 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6220 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Recent Insights on the Medicinal Chemistry of Metal-Based Compounds: Hints for the Successful Drug Design
Current Medicinal Chemistry The Roles of MicroRNAs in Atherosclerosis
Current Medicinal Chemistry Resistance to Anti-VEGF Agents
Current Pharmaceutical Design Merging Traditional Chinese Medicine with Modern Drug Discovery Technologies to Find Novel Drugs and Functional Foods
Current Drug Discovery Technologies Frailty of Older Age: The Role of the Endocrine - Immune Interaction
Current Pharmaceutical Design Therapeutic Use of Heat Shock Protein 70
Recent Patents on DNA & Gene Sequences TNFα as Therapeutic Target: New Drugs, More Applications
Current Drug Targets - Inflammation & Allergy Anti-inflammatory Effects of Rosuvastatin in Healthy Subjects: A Prospective Longitudinal Study
Current Pharmaceutical Design The Adenosine A2b Receptor: Its Role in Inflammation
Endocrine, Metabolic & Immune Disorders - Drug Targets Are Tender Point Injections Beneficial: The Role of Tonic Nociception in Fibromyalgia
Current Pharmaceutical Design MicroRNA-16-5p Controls Development of Osteoarthritis by Targeting SMAD3 in Chondrocytes
Current Pharmaceutical Design Natural Compounds and Plant Extracts as Therapeutics Against Chronic Inflammation in Alzheimer's Disease - A Translational Perspective
CNS & Neurological Disorders - Drug Targets Therapeutic Approaches for Reducing C-Reactive Protein (CRP) Levels and the Associated Cardiovascular Risk
Current Chemical Biology Editorial [ UCTD and Unfinished Business ]
Current Rheumatology Reviews Impact of Renin-Angiotensin System in Hepatocellular Carcinoma
Current Cancer Drug Targets Inhibition of Matrix Metalloproteinases as a Feasible Therapeutic Target in Rheumatoid Arthritis
Current Rheumatology Reviews Regenerative Therapies in Cartilage and Bone: Current Patents, Technologies, and Emerging Applications
Recent Patents on Regenerative Medicine Network Pharmacology: Reigning in Drug Attrition?
Current Drug Discovery Technologies Gene Polymorphisms and Pharmacogenetics in Rheumatoid Arthritis
Current Genomics New Therapies in SLE
Recent Patents on Inflammation & Allergy Drug Discovery